Review · Not a partner
$324 buys a month at Wisp — $225 for compounded sublingual semaglutide plus a $99 consult that recurs. It is also the only company on this roster that says some medication may be sourced abroad.
They advertise
A month with no commitment
$324/mo, month to month
Price read from Wisp's own page
Not a partner. Links to Wisp go to their own site and pay us nothing. Who pays us.
Compare every priced provider →Wisp is a large sexual and reproductive health service — birth control, UTIs, herpes, STI kits, PrEP, menopause, skincare, some 205 products — with weight care as one shelf among many.
It is also the only company on this roster that tells you, on the page selling the drug, that some of what it dispenses may come from outside the country. That disclosure is the most important thing here, and Wisp made it voluntarily.
The gap
They advertise $225 a month. That is the medication only. A membership is required on top, so a month actually costs $324.
| Plan | Per month | Charged today |
|---|---|---|
Sublingual, per 28-day supply · advertisedSource$225/ month◉ In Stockhttps://hellowisp.com/products/compounded-sublingual-semaglutide — read 2026-09-02 | $225 | $225 |
One rung, and it is the only medication Wisp prices. ⛔ Read the unit: the buy box says “$225/ month” and the product detail says “28 day supply”, which is thirteen fills in a year rather than twelve. There is no term ladder — every control in the buy box, nine of them, leaves that figure exactly where it is — and Wisp's own Subscribe & Save page lists no GLP-1 at all.
$99 a month for the consult, and it recurs. Wisp's own answer to what weight care costs: “Our Weight Care Consult starts at $99/month… Depending on treatment, medication costs will apply when you pick up your meds at your local pharmacy or upon checkout if choosing free delivery.” Three weeks in, your card is authorized for the next $99, and “The same process will continue each month thereafter.”
The one medication Wisp prices is compounded sublingual semaglutide at $225. So a month is $324 — and the $225 buys a “28 day supply”, which fits thirteen times into a year, not twelve.
For Wegovy, Zepbound and Saxenda, the $99 on the product page is the consult and nothing else. Those three say “Local pick-up only”: Wisp writes the prescription, your pharmacy fills it, and your pharmacy sets the price. Wisp never charges it and never publishes it, which is an answer, not a gap.
There is one more charge, for a visit that produces nothing: if every prescription in an order is declined, “you will be charged a fee of up to $25 instead of the full consult price”. If one is approved, it is not charged.
The supplement on the same shelf is not a GLP-1 and is not priced here. “Wisp Metabolic Support & GLP-1 Boost Capsules” at $54 a month is a dietary supplement — lemon peel extract, black ginger, dihydroberberine — carrying the FDA disclaimer and Wisp's own warning that it is “not to be used together” with GLP-1 medication.
Wisp gets one thing badly wrong on its own Wegovy page: “Wegovy, Saxenda, and Zepbound are FDA-approved injectable prescriptions that contain semaglutide.” Saxenda is liraglutide and Zepbound is tirzepatide, as Wisp's own pages for those two drugs correctly say.
The full breakdown — what is included, what is extra, and what happens at higher doses — is on the Wisp cost page.
Anyone who needs to know where their medication comes from and wants the answer to be here. Wisp says some medication may be globally sourced — which is more than anyone else on this roster says, and it is still a maybe.
Anyone pricing a brand pen. The $99 on the Wegovy, Zepbound and Saxenda pages is the consult; the drug is billed by your own pharmacy at a price Wisp does not state.
Anyone budgeting twelve payments for the sublingual. It is a 28-day supply sold as a month.
Anyone trying to work out whether Wisp covers their state from its FAQs. Four of its own GLP-1 pages publish four different state lists, running from 39 states down to 21, and one of them says sublingual semaglutide is available in Oregon only while the product page sells it to 27 states.
These are the checks this site applies to every company — how we review. Not stated means we could not find it on their site, which is a finding about the site, not about the company.
Read September 2, 2026. Twenty-one of Wisp's own pages, drawn from a sitemap of 763 URLs — /shop/weight-care, /products/weight-care-consult, /products/compounded-sublingual-semaglutide, /products/wegovy, /products/zepbound, /products/saxenda, /products/metabolic-glp-support-capsules, /products/wisp-plus-membership, /pricing, /provider-credentials, /terms, /privacy, /shipping, /how-it-works, /informed-consent, /medical-terms-of-service, /third-party-list, /subscriptions, /learn/faq and the home page — plus three attempts at the intake modal. Every FAQ answer quoted here was opened with a real click and the reveal count recorded per page.
★ The overseas disclosure, quoted in full because it is the first on this roster. /informed-consent: “Some medications may be globally sourced. I understand that in order to keep medication costs down, some of Wisp's mail-order partners may use pharmacies that globally source certain drugs prescribed to me. I understand that the product website and treatment guide will indicate whether my prescription is being sourced globally.” And on the weight-care category page itself: “This product has not been evaluated by the FDA. The globally sourced medications offered are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you acknowledge that you are assuming the risks of using a globally sourced, non-FDA-approved product for personal use and that custom delays may occur during shipment.” The privacy policy adds “the dispensing pharmacy regulations and policies, including international pharmacies if applicable”. Wisp does not say which medications, and this record does not guess.
The prices, quoted from the buy boxes: “$225/ month◉ In Stock” on the compounded sublingual semaglutide page, with “28 day supply” in its own product detail; “Starting at$99/ month◉ In Stock” on Wegovy under the line “Local pick-up only”; “$99/ Month◉ In Stock” on Zepbound and “$99/ month◉ In Stock” on Saxenda, both under the same line. The full cost answer, from /shop/weight-care: “Our Weight Care Consult starts at $99/month”, “Depending on treatment, medication costs will apply when you pick up your meds at your local pharmacy or upon checkout if choosing free delivery.”, “Your card on file will be authorized for $99 (but not yet charged) so your provider can review your medical progress and make any necessary adjustments for your first refill.”, “The same process will continue each month thereafter.”
No term ladder, and how that was tested rather than assumed. Every control in the buy-box region of the sublingual page was clicked — nine of them, including Free Delivery, Same-Day Pickup and each accordion — and the string “$225/ month” was byte-identical after every one. A 30-screen walk of the same page produced the same line on all 30. Wisp's Subscribe & Save page lists no GLP-1; the only multi-month offers on the site are the Wisp+ membership and the supplement.
The declined-order fee, quoted from /learn/faq: “This fee covers the clinical time a licensed Wisp provider spent reviewing your order when they're unable to prescribe any of the requested treatments. It only applies if every prescription in your order is declined — if at least one is approved, no fee is charged.” /how-it-works gives the amount: “you will be charged a fee of up to $25 instead of the full consult price”.
The supplement, kept off the ladder deliberately. “Wisp Metabolic Support & GLP-1 Boost Capsules”, “Starting at$54/ month”, “Per month for 6 months”, is a dietary supplement: “Ingredients: Eriomin® lemon peel bioflavonoid extract, Actiz!ng™ black ginger root extract, Glucovantage® dihydroberberine, PoZibio™, hypomellose (capsule)”, carrying “These statements have not been evaluated by the Food and Drug Administration.” and “Note: Weight loss prescription product/GLP-1 medications and GLP-1 Support Capsules are not to be used together.” It names no molecule and is not a GLP-1.
★ Why the licensure row reads Not stated, when Wisp arguably does more than anyone. A search of 21 pages for a sentence saying the prescriber is licensed in the patient's own state returns zero hits. What Wisp publishes instead is /provider-credentials: 24 named clinicians with 978 individual state license numbers between them, printed in full. That is a stronger disclosure than most sentences on this roster — but it is a roster of licenses, not a statement about the reader's prescriber, and this site records what a company states. The “all 50 states” line on /how-it-works is about shipping and does not count.
Four state lists for one product line, all on Wisp's own GLP-1 pages. /products/weight-care-consult answers “Which states are eligible for branded injectables?” with 39 states. /products/wegovy, /products/zepbound and /products/saxenda answer the same question with 28, none of them including the twelve extra on the first list. /products/compounded-sublingual-semaglutide answers it with 27. The intake modal itself offers 21. Separately, /products/weight-care-consult says sublingual semaglutide is available in Oregon only, while the product page lists 27 states and takes orders.
The pharmacology error, quoted from /products/wegovy: “Wegovy, Saxenda, and Zepbound are FDA-approved injectable prescriptions that contain semaglutide.” Saxenda is liraglutide and Zepbound is tirzepatide; Wisp's own pages for both name the correct molecule.
Two descriptions of the same pharmacy on one page. /products/weight-care-consult: “No, compounded semaglutides are not FDA-approved; however, we utilize an FDA-regulated 503A compounding pharmacy.” And, two answers later on the same page, “Wisp uses an FDA- approved pharmacy to compound the medication.” FDA does not approve pharmacies; the same page also carries an explainer defining a 503B outsourcing facility, which is not what Wisp says it uses.
The entity: “Wisp, Inc.”, 548 Market Street, Suite 52789, San Francisco, California 94104, from /terms §18.6. The footer reads “© 2026 wisp, Inc.”
Screened against FDA's published enforcement index on September 2, 2026 and nothing is filed against this company. The screen ran over all 3,664 letters on the strings Wisp and hellowisp and returned no match; the same screen in the same pass returns the three letters this roster already carries for Hims, Hers and Levity.
What we did not find, and where we looked. Across the 21 pages we searched for a named dispensing pharmacy and for an out-of-pocket price for Wegovy, Zepbound or Saxenda. No pharmacy is named anywhere — every mention is generic, “your local pharmacy”, “our mail order pharmacy partners”, “an FDA-regulated 503A compounding pharmacy”. The brand prices are not published because Wisp does not charge them; the patient pays their own pharmacy. Wisp's intake modal closes rather than advancing after its state gate in a headless browser, on three separate attempts, so its post-state screens were not seen and nothing is asserted about them.
⚠ A trap for anyone re-reading this corpus. Several walked screens contain the strings $10, $12, $140 and $60. None is a Wisp price: all four are verbatim customer-review prose about unrelated products that rotated into view during the walk.
The same molecules at every other company we have reviewed, with the range each one falls in.
Words used above: Compounded, 503A, 503B, Membership, Overseas fulfillment. All of them are in the glossary.
Not a partner. This link goes to Wisp and pays us nothing. Who pays us.
Every company we have reviewed is on the reviews index. See who writes these reviews. Your privacy choices and the terms of use apply to this page.